Want to see DE:AJ91 full AI Analyst Report?

DocCheck AG (AJ91) Price & Analysis

3 Followers

AJ91 Stock Chart & Stats

€11.10

-€0.10(-0.86%)

At close: Jul 27 4:00 PM EDT

€11.10

-€0.10(-0.86%)

Day’s Range― - ―

52-Week Range€10.60 - €15.90

Previous CloseN/A

Volume1.01K

Average Volume (3M)506.00

Market Cap

€55.81M

Enterprise Value€48.03

Total Cash (Recent Filing)€18.54M

Total Debt (Recent Filing)€4.16M

Price to Earnings (P/E)10.5

Beta0.54

Next Earnings

Feb 05, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield9.09%

Share Statistics

EPS (TTM)1.05

Shares Outstanding5,073,816

10 Day Avg. Volume507

30 Day Avg. Volume506

Financial Highlights & Ratios

PEG Ratio12.18

Price to Book (P/B)1.50

Price to Sales (P/S)1.13

P/FCF Ratio23.88

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a strong equity base reduce financial risk and preserve flexibility for investment, dividends, or resilience if healthcare-sector marketing demand weakens.

Healthy ProfitabilitySustained positive margins show that DocCheck’s digital services model can remain economically viable despite slower growth, supporting continued earnings generation and internal funding.

Specialized Healthcare PlatformA healthcare-professional-focused platform gives DocCheck a specialized audience and supports targeted campaigns for industry clients, creating a durable niche versus broad, undifferentiated digital advertising.

Bears Say

Weak Revenue TrajectoryRecent revenue contraction indicates weaker demand or execution momentum, limiting operating leverage and making sustained earnings growth less dependable over the next several reporting periods.

Inconsistent Cash ConversionVolatile free cash flow and operating cash flow covering only slightly more than half of accounting profit reduce cash-flow quality and may constrain distributions or reinvestment capacity.

Profitability Below Prior PeaksThe normalization of earnings from earlier highs suggests the business has lost some growth efficiency; continued pressure could make current margins harder to sustain if revenue remains flat or declining.

DocCheck AG News

DocCheck AG (AJ91) Unveils Dividend Details for Q2: Mark Your Calendar!

DocCheck AG (XETRA: AJ91) has declared, under its dividend policy, a yearly cash dividend in the amount of...

1y ago

DocCheck AG (AJ91) Announces Q2 Dividend: Read On for Important Dates

DocCheck AG (XETRA: AJ91) has declared, under its dividend policy, a yearly cash dividend in the amount of...

2y ago

AJ91

AJ91 FAQ

What was DocCheck AG’s price range in the past 12 months?

DocCheck AG lowest stock price was €10.60 and its highest was €15.90 in the past 12 months.

What is DocCheck AG’s market cap?

DocCheck AG’s market cap is €55.81M.

When is DocCheck AG’s upcoming earnings report date?

DocCheck AG’s upcoming earnings report date is Feb 05, 2027 which is in 144 days.

How were DocCheck AG’s earnings last quarter?

DocCheck AG released its earnings results on Feb 06, 2026. The company reported €0.567 earnings per share for the quarter.

Is DocCheck AG overvalued?

According to Wall Street analysts DocCheck AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does DocCheck AG pay dividends?

DocCheck AG pays a Annually dividend of €1 which represents an annual dividend yield of 9.09%. See more information on DocCheck AG dividends here

What is DocCheck AG’s EPS estimate?

DocCheck AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does DocCheck AG have?

DocCheck AG has 5,073,816 shares outstanding.

What happened to DocCheck AG’s price movement after its last earnings report?

DocCheck AG reported an EPS of €0.567 in its last earnings report. Following the earnings report the stock price went down -1.739%.

Which hedge fund is a major shareholder of DocCheck AG?

Currently, no hedge funds are holding shares in DE:AJ91

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

DocCheck AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

9.09%

Trailing 12-Months

Asset Growth

-8.52%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

DocCheck AG

DocCheck AG offers community, agency, and e-commerce services for the healthcare sector in Europe. The company develops and implements communication strategies for media on healthcare and business-to-business sectors; sells medical supplies and medical technology primarily via mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.